the cutaneous application of the substance has evidenced enhanced carcinogenesis under the exposure to a larger of the two dosages : skin tumors in the experimental group were noted in 68.75 % of animals , in the control group ( application of the carcinogen ) -- in 19.44 % .
C0037267
the cutaneous
C0037286
skin tumors